Publication | Closed Access

Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells

InflammationAnti-inflammatorySignal TransductionMedicineInnate Immune SystemImmunologyTlr4-myd88-mediated InhibitionInflammatory Mediator ExpressionInnate ImmunityPharmacologyCell SignalingLipopolysaccharide-stimulated Raw264.7Molecular Signaling